News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
China’s Fosun International Ltd. Prices $1.5 Billion HK IPO at Top of Range
July 6, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
HONG KONG, July 6 (Reuters) - China's top privately owned conglomerate, Fosun International Ltd., raised US$1.48 billion, pricing its Hong Kong initial public offering at the top of an indicated range, sources familiar with the deal said on Friday.
Twitter
LinkedIn
Facebook
Email
Print
IPO
Asia
MORE ON THIS TOPIC
Podcast
Lilly’s Obesity Pill Heads to the FDA, AbbVie Bets on Psychedelics, HHS Unveils More Change
August 27, 2025
·
1 min read
·
Jef Akst
IPO
Biotech Finally Has an IPO After Months-Long Freeze
August 25, 2025
·
1 min read
·
Annalee Armstrong
Acquisitions
Unswayed by Cerevel Failure, AbbVie Buys Gilgamesh’s Depression Drug for $1.2B
August 25, 2025
·
3 min read
·
Annalee Armstrong
IN PARTNERSHIP WITH CRESSET
Why AI Won’t Save the 90% of Clinical Trials That Still Fail
August 21, 2025
·
1 min read
·
Lori Ellis